Fig. 5From: Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironmentForest plots. A univariate analysis that validate the effect of overall survival showed that “high objective response rate” and “progression due to pre-existing lesions and high-TILs” were considered as factors for a good prognosis (p = 0.006; HR = 0.160) (p = 0.020; HR = 0.221)Back to article page